Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 69

1.

Predicting abstinence from methamphetamine use after residential rehabilitation: Findings from the Methamphetamine Treatment Evaluation Study.

McKetin R, Kothe A, Baker AL, Lee NK, Ross J, Lubman DI.

Drug Alcohol Rev. 2017 Apr 18. doi: 10.1111/dar.12528. [Epub ahead of print]

PMID:
28421682
2.

Health service utilisation attributable to methamphetamine use in Australia: Patterns, predictors and national impact.

McKetin R, Degenhardt L, Shanahan M, Baker AL, Lee NK, Lubman DI.

Drug Alcohol Rev. 2017 Mar 12. doi: 10.1111/dar.12518. [Epub ahead of print]

PMID:
28294443
3.

Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders.

McKetin R, Baker AL, Dawe S, Voce A, Lubman DI.

Psychiatry Res. 2017 May;251:349-354. doi: 10.1016/j.psychres.2017.02.028. Epub 2017 Feb 13.

PMID:
28282630
4.

Polysubstance use in treatment seekers who inject amphetamine: Drug use profiles, injecting practices and quality of life.

Kelly PJ, Robinson LD, Baker AL, Deane FP, McKetin R, Hudson S, Keane C.

Addict Behav. 2017 Feb 10;71:25-30. doi: 10.1016/j.addbeh.2017.02.006. [Epub ahead of print]

PMID:
28242532
5.

A longitudinal examination of the relationship between cannabis use and cognitive function in mid-life adults.

McKetin R, Parasu P, Cherbuin N, Eramudugolla R, Anstey KJ.

Drug Alcohol Depend. 2016 Dec 1;169:134-140. doi: 10.1016/j.drugalcdep.2016.10.022. Epub 2016 Oct 25.

PMID:
27810656
6.

Estimating the number of regular and dependent methamphetamine users in Australia, 2002-2014.

McKetin R, Degenhardt L, Hall WD.

Med J Aust. 2016 Nov 7;205(9):426. No abstract available.

PMID:
27809743
7.

Crystalline methamphetamine use and methamphetamine-related harms in Australia.

Degenhardt L, Sara G, McKetin R, Roxburgh A, Dobbins T, Farrell M, Burns L, Hall WD.

Drug Alcohol Rev. 2017 Mar;36(2):160-170. doi: 10.1111/dar.12426. Epub 2016 Jun 11.

PMID:
27286742
8.

A potential role for N-acetylcysteine in the management of methamphetamine dependence.

McKetin R, Dean OM, Baker AL, Carter G, Turner A, Kelly PJ, Berk M.

Drug Alcohol Rev. 2017 Mar;36(2):153-159. doi: 10.1111/dar.12414. Epub 2016 May 30.

PMID:
27241765
9.

Will the Australian Government's response to its 'National Ice Taskforce' deliver more treatment as promised?

McKetin R.

Drug Alcohol Rev. 2016 May;35(3):247-9. doi: 10.1111/dar.12423. No abstract available.

PMID:
27120314
10.

Correlates of transient versus persistent psychotic symptoms among dependent methamphetamine users.

McKetin R, Gardner J, Baker AL, Dawe S, Ali R, Voce A, Leach LS, Lubman DI.

Psychiatry Res. 2016 Apr 30;238:166-71. doi: 10.1016/j.psychres.2016.02.038. Epub 2016 Feb 18.

PMID:
27086229
11.

Non-Fatal Injury in Thailand From 2005 to 2013: Incidence Trends and Links to Alcohol Consumption Patterns in the Thai Cohort Study.

Wakabayashi M, Berecki-Gisolf J, Banwell C, Kelly M, Yiengprugsawan V, McKetin R, Seubsman SA, Iso H, Sleigh A, Thai Cohort Study Team T.

J Epidemiol. 2016 Sep 5;26(9):471-80. doi: 10.2188/jea.JE20150218. Epub 2016 Mar 5.

12.

Estimating the number of regular and dependent methamphetamine users in Australia, 2002-2014.

Degenhardt L, Larney S, Chan G, Dobbins T, Weier M, Roxburgh A, Hall WD, McKetin R.

Med J Aust. 2016 Mar 7;204(4):153.

PMID:
26937668
13.

The profile of psychiatric symptoms exacerbated by methamphetamine use.

McKetin R, Dawe S, Burns RA, Hides L, Kavanagh DJ, Teesson M, McD Young R, Voce A, Saunders JB.

Drug Alcohol Depend. 2016 Apr 1;161:104-9. doi: 10.1016/j.drugalcdep.2016.01.018. Epub 2016 Jan 30.

PMID:
26874915
14.

Alcohol consumption patterns in Thailand and their relationship with non-communicable disease.

Wakabayashi M, McKetin R, Banwell C, Yiengprugsawan V, Kelly M, Seubsman SA, Iso H, Sleigh A; Thai Cohort Study Team..

BMC Public Health. 2015 Dec 24;15:1297. doi: 10.1186/s12889-015-2662-9.

15.

Prescription opioid analgesics for pain management in Australia: 20 years of dispensing.

Islam MM, McRae IS, Mazumdar S, Taplin S, McKetin R.

Intern Med J. 2016 Aug;46(8):955-63. doi: 10.1111/imj.12966. Erratum in: Intern Med J. 2016 Aug;46(8):963.

PMID:
26602489
16.

Heavy cannabis users at elevated risk of stroke: evidence from a general population survey.

Hemachandra D, McKetin R, Cherbuin N, Anstey KJ.

Aust N Z J Public Health. 2016 Jun;40(3):226-30. doi: 10.1111/1753-6405.12477. Epub 2015 Nov 11.

PMID:
26558539
17.

Six-month outcomes of a Web-based intervention for users of amphetamine-type stimulants: randomized controlled trial.

Tait RJ, McKetin R, Kay-Lambkin F, Carron-Arthur B, Bennett A, Bennett K, Christensen H, Griffiths KM.

J Med Internet Res. 2015 Apr 29;17(4):e105. doi: 10.2196/jmir.3778.

18.

Typologies of positive psychotic symptoms in methamphetamine dependence.

Bousman CA, McKetin R, Burns R, Woods SP, Morgan EE, Atkinson JH, Everall IP, Grant I; Translational Methamphetamine AIDS Research Center (TMARC) Group..

Am J Addict. 2015 Mar;24(2):94-7. doi: 10.1111/ajad.12160.

19.

A comprehensive review of the effects of mixing caffeinated energy drinks with alcohol.

McKetin R, Coen A, Kaye S.

Drug Alcohol Depend. 2015 Jun 1;151:15-30. doi: 10.1016/j.drugalcdep.2015.01.047. Epub 2015 Feb 24. Review.

PMID:
25861944
20.

Primary and substance-induced psychotic disorders in methamphetamine users.

Hides L, Dawe S, McKetin R, Kavanagh DJ, Young RM, Teesson M, Saunders JB.

Psychiatry Res. 2015 Mar 30;226(1):91-6. doi: 10.1016/j.psychres.2014.11.077. Epub 2014 Dec 18.

PMID:
25677394

Supplemental Content

Loading ...
Support Center